Photodynamic Therapy of Subfoveal Choroidal Neovascularization-Interval and Number of Application of Verteporfin Treatment.

Lee, Dong Won; Kwon, Oh Woong

Original Article

Journal of the Korean Ophthalmological Society 2004;45(5):736-743.
Published online May 1, 2004.

Photodynamic Therapy of Subfoveal Choroidal Neovascularization-Interval and Number of Application of Verteporfin Treatment.

Dong Won Lee, Oh Woong Kwon

¹Department of Ophthalmology, Dong-a University, College of Medicine, Dongdaeshin-dong, Seo-gu, Busan, Korea. mediceye@yahoo.co.kr
²Department of Ophthalmology, Yonsei University, College of Medicine, Korea.

맥락막신생혈관에 시행한 광역학요법의 치료 간격 및 횟수에 대하여

이동원 ( Lee Dong Won ) , 권오웅 ( Kwon O Ung )

Abstract

PURPOSE
To evaluate the interval between, and the total number of, applications of photodynamic therapy in-patients with subfoveal choroidal neovascularization caused by various etiologies. METHODS: Ninety-five patients (108 eyes) received photodynamic therapy. At follow-up examination every 6 weeks, retreatment with the same regimen was applied if angiography showed definite fluorescein leakage. We retrospectively evaluated the interval between treatments and their total number in the group of patients who were able to be followed up for more than 6 months. RESULTS: The average number of applications of verteporfin treatment was 2.46 over a mean follow-up of 14.93 months. The average interval between treatments was 3.65 months. CONCLUSIONS: Further evaluation is needed to analyze the results of photodynamic therapy in Koreans and thereby produce a set of more accurate guidelines.

Key Words: Choroidal neovascularization;Photodynamic therapy;Verteporfin